Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Blood pressure medicines: how each kind works

Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

There are four main classes used first, and they lower blood pressure by roughly similar amounts while differing in who they suit and what they do besides.

The most useful thing to understand is that combining two at low dose lowers pressure more and causes fewer side effects than pushing one to its maximum, which is why most people end up on more than one tablet.

Related pages: High blood pressure (hypertension)

The bottom line

What we know
  • ACE inhibitors, ARBs, calcium channel blockers and thiazide-like diuretics are the first-line classes.
  • Combining two drugs at low dose is more effective than doubling one.
  • ACE inhibitors and ARBs must not be used in pregnancy.
  • Taking antihypertensives at night rather than morning did not improve outcomes in a large randomized trial.
What is still open
  • Which drug suits which individual, where prediction remains poor.
  • How much the choice between thiazide-type diuretics matters at equivalent doses.

The story, step by step

  1. 1. The four ()
  2. 2. The others ()
  3. 3. Combinations ()
  4. 4. Living with the tablets ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 4

What each class does

Review of many studies

What happens

The first-line options.

What the research shows

  • ACE inhibitors, with names ending in -pril, block production of angiotensin II. They protect the kidney in people with albuminuria and are used after heart attack and in heart failure. The characteristic side effect is a dry persistent cough, in up to one in ten, which is not dangerous but is a reason to switch. Angioedema, swelling of the lips, tongue or throat, is rare, more common in Black patients, and is a medical emergency.
  • ARBs, with names ending in -sartan, block the angiotensin receptor instead. Similar benefits, far less cough, lower angioedema risk. ACE inhibitors and ARBs are not combined with each other.
  • Calcium channel blockers, such as amlodipine, relax arterial muscle. Effective across groups, particularly useful in older adults and in Black patients, and the common side effect is ankle swelling, which is dose-related and often improved by adding an ACE inhibitor or ARB rather than increasing the dose.
  • Thiazide-like diuretics, such as chlorthalidone and indapamide, reduce volume and have longer-lasting effects than hydrochlorothiazide, which several guidelines now prefer them over. They lower potassium and sodium, raise uric acid and can trigger gout, and need periodic blood tests.
  • Both ACE inhibitors and ARBs are contraindicated in pregnancy and in anyone who might become pregnant without contraception, because of serious fetal harm. This is one of the firmest rules in the field.

Why it matters

All four lower pressure by broadly similar amounts. The choice is about what else the person has, not about potency.

What's still uncertain

  • Whether chlorthalidone's advantage over hydrochlorothiazide holds at equivalent doses, which a recent trial questioned.

Read more

Next: The others

Part 2 of 4

Beta-blockers and the rest

Review of many studies

What happens

Classes used for specific reasons.

What the research shows

  • Beta-blockers are no longer first-line for uncomplicated hypertension, because they prevent stroke less well than the other classes. They remain first choice when there is another reason for them: angina, previous heart attack, heart failure, or rate control in atrial fibrillation.
  • They should not be stopped abruptly, because rebound increases in heart rate and pressure can precipitate angina or worse. They are tapered.
  • Spironolactone and eplerenone block the aldosterone receptor and are the most effective fourth drug in resistant hypertension. They raise potassium, so blood tests are required, and spironolactone can cause breast tenderness or enlargement in men.
  • Alpha-blockers, such as doxazosin, lower pressure and treat prostate symptoms, and cause dizziness on standing.
  • Hydralazine, minoxidil, clonidine and others are reserved for specific situations, usually under specialist care.
  • In pregnancy the usual choices are labetalol, nifedipine and methyldopa, and the whole approach is different.
  • Loop diuretics such as furosemide are used for blood pressure mainly when kidney function is reduced or there is fluid overload.

Why it matters

Beta-blockers being dropped from first-line is a change many people on them have never had explained, and it does not mean anyone's prescription is wrong.

What's still uncertain

  • Whether newer vasodilating beta-blockers perform better in hypertension than older ones.

Read more

Next: Combinations

Part 3 of 4

Why most people need more than one

Review of many studies

What happens

The arithmetic of blood pressure treatment.

What the research shows

  • Doubling the dose of a single drug typically produces only a small additional fall in pressure, while roughly doubling the dose-related side effects.
  • Adding a second class at low dose produces about five times the additional effect of doubling the first, because the two work on different mechanisms.
  • This is why most people with stage 2 hypertension are started on two drugs, and why needing several tablets is a feature of the disease rather than a sign of failure.
  • Single-pill combinations, with two or three drugs in one tablet, improve adherence substantially and are widely underused.
  • Common pairings: an ACE inhibitor or ARB with a calcium channel blocker, or with a thiazide-like diuretic. The ACE inhibitor or ARB also offsets the ankle swelling from the calcium channel blocker and the potassium loss from the diuretic.
  • Three drugs from different classes, including a diuretic, is the usual maximum before a condition is called resistant and investigated further.
  • It typically takes several weeks for a dose change to show its full effect, so adjustments are not made day to day.

Why it matters

People often interpret a second tablet as their condition worsening. It usually means the treatment is being done properly.

What's still uncertain

  • How best to sequence drug classes for an individual, where evidence supports several orders.

Read more

Next: Living with the tablets

Part 4 of 4

Timing, side effects and stopping

Review of many studies

What happens

The practical questions people actually ask.

What the research shows

  • Timing: for years people were advised to take antihypertensives at night, on the basis of one trial. The much larger TIME trial randomized evening against morning dosing and found no difference in cardiovascular outcomes. Take them whenever you will reliably remember.
  • Diuretics are usually taken in the morning simply to avoid night-time urination.
  • Never stop abruptly, particularly beta-blockers and clonidine, which cause rebound. If a medicine is causing problems, report it rather than discontinuing.
  • Feeling fine is not a reason to stop. It is the expected state, and stopping returns pressure to where it was within days to weeks.
  • Side effects worth reporting promptly: swelling of the face, lips or tongue, fainting or near-fainting, a persistent dry cough, muscle cramps or weakness, very low readings, gout, or a rash.
  • Dizziness on standing is common early and often settles. If it persists, standing blood pressure should be measured rather than the symptom tolerated.
  • Erectile dysfunction is attributed to these drugs more often than it is caused by them, and it is also a marker of vascular disease. Worth discussing rather than quietly stopping treatment.
  • Grapefruit interacts with some calcium channel blockers. NSAIDs blunt most antihypertensives and raise pressure directly.
  • Adherence in real life is poor, often under half of prescribed doses over a year. Simplifying the regimen, using combination pills and linking doses to an existing daily routine do more than reminders.

Why it matters

Stopping because you feel well is the single commonest reason treatment fails, and it follows directly from the condition having no symptoms.

What's still uncertain

  • How best to support long-term adherence, which remains the field's largest unsolved practical problem.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.